ERS 2026: BMI, type-2 inflammation, and asthma attack risk - Pharmaceutical Technology

At ERS 2026, investigators reported their findings from their review of the Oxford Asthma Attack Risk Scale Meta-Analysis (ORACLE2). Investigators performed a meta-analysis of the ORACLE2 dataset, reviewing pooled data from 6,513 control-arm participants, aged 12 years and above, from 22 clinical trials. Conversely, the BMI impact on inflammatory T2 biomarkers has not been well characterised. Credit: SergioVas via Shutterstock.com. Unlock FREE Access to Premium Content ​Discover exclusive forecasts, analyst insights, and in-depth pharmaceutical industry analysis spanning drug development, manufacturing, regulation, and global healthcare trends. With a free Pharmaceutical Technology profile, you can: The leading site for news and procurement…

Source: Pharmaceutical Technology